Cas:183383-30-4 tert-butyl 4-formylpiperazine-1-carboxylate manufacturer & supplier

Chemical Name:tert-butyl 4-formylpiperazine-1-carboxylate

CAS.NO:183383-30-4

Synonyms:4-Bromoindole,N-BOC protected;N-Boc-4-bromoindole;4-bromo-indole-1-carboxylic acid tert-butyl ester;1-Boc-4-Bromoindole;1-Boc-4-formylpiperazine;N-Boc-4-formylpiperazine;tert-butyl 4-bromo-1H-indole-1-carboxylate;4-bromo-N-Boc-indole

Molecular Formula:C₁₀H₁₈N₂O₃

Molecular Weight:214.26200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:49.85000

Exact Mass:214.13200

LogP:1.20720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Bromoindole,N-BOC protected chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-bromo-N-Boc-indole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromoindole,N-BOC protected Use and application,N-Boc-4-formylpiperazine technical grade,usp/ep/jp grade.

Related News: The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. N-Methyl-2′-nitrobiphenyl-2-carboxamid manufacturers The Ballina facility was first established in 1974 and was acquired by Charles River in 2002. Over the years it has added to its capabilities offering a comprehensive package of GMP services in support of recombinant biologics, vaccines, cell and gene therapies, biosimilars, and medical devices. Charles River now employs 230 people at two facilities in Ireland: the site in Ballina Co. Mayo which focuses on biologics testing, and a site in Dublin, established in 2017, which serves as the EMEA and APAC headquarters for the Company’s Microbial Solutions division. N-(4-(2-aminothiazol-4-yl)phenyl)-3-((cyclohexylmethyl)amino)propanamide suppliers Developed in collaboration with the sector, including academia, industry and charities with organizations such as Universities UK and GSK, 5β-Androstan-17β-ol-3-on-anti-methyloxim vendor & factory The expansion will include six 1,000L small molecule reactors, four 1,500L vessels, and isolation equipment providing mid-scale capacity to bridge between early-phase and late-phase production. ,Zynteglo, a gene therapy for the blood disorder beta thalassaemia, uses a viral vector (or modified virus) to deliver a working gene into the patient’s blood cells.